Discordance Between Glycated Hemoglobin A 1 c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
Philippe OriotClaire ViryAntoine VandelaerSébastien GrigioniMalanie RoyJean Christophe PhilipsGaëtan PrévostPublished in: Journal of diabetes science and technology (2022)
HbA1c-GMI discordance is frequent and usually in favor of an HbA1c level higher than the GMI value, which can lead to errors in changes in glucose-lowering therapy, especially for individuals with CKD. This latter population should benefit from the CGM to measure their glucose exposure more precisely.